Invesaro

Stocks Health care ILMN

NASDAQ · Health care

Illumina, Inc. (ILMN)

Operating cash flow minus capital spending left $931M of free cash flow in fiscal 2025. At June 28, 2026 it held $1B in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 31, 2026.

Price
$270.00
-1.42% on the day · September 25, 2026
52-week range $88.00 to $277.95
Market cap
$40.8B
P/E
49.5
on FY2025 diluted EPS

What Illumina, Inc. does

Illumina, Inc. is registered with the SEC under industry code SIC 3826 (Laboratory Analytical Instruments). Its shares trade on NASDAQ under the ticker ILMN.

Revenue and profit by year

Revenue
FY18: $3.3B $3.3B FY18FY19: $3.5B $3.5B FY19FY20: $3.2B $3.2B FY20FY21: $4.5B $4.5B FY21FY22: $4.6B $4.6B FY22FY23: $4.5B $4.5B FY23FY24: $4.4B $4.4B FY24FY25: $4.3B $4.3B FY25
Net income
FY18: $826M $826M FY18FY19: $1B $1B FY19FY20: $656M $656M FY20FY21: $762M $762M FY21FY22: -$4.4B -$4.4B FY22FY23: -$1.2B -$1.2B FY23FY24: -$1.2B -$1.2B FY24FY25: $850M $850M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$4.3B$807M$850M$5.45$931M
2024$4.4B-$833M-$1.2B-$7.69$709M
2023$4.5B-$1.1B-$1.2B-$7.34$283M
2022$4.6B-$4.2B-$4.4B-$28.00$106M
2021$4.5B-$123M$762M$5.04$337M
2020$3.2B$580M$656M$4.45$891M

Latest SEC filings

What Illumina, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 17, 2026
    Other event 8-K
  2. August 13, 2026
    Material agreement 8-K
  3. August 12, 2026
    Securities offering prospectus 424B2
  4. August 12, 2026
    Other event 8-K
  5. August 10, 2026
    Offering term sheet FWP
  6. August 10, 2026
    Securities offering prospectus 424B2
  7. August 7, 2026
    Other event 8-K
  8. July 31, 2026
    Quarterly report 10-Q · period to June 28, 2026
  9. July 30, 2026
    Quarterly results 8-K
  10. June 23, 2026
    Executive or director change 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 10, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about ILMN

What does Illumina, Inc. do?

Illumina, Inc. is registered with the SEC under industry code SIC 3826 (Laboratory Analytical Instruments). Its shares trade on NASDAQ under the ticker ILMN.

Is Illumina, Inc. profitable?

Yes. Over the twelve months to June 28, 2026 it reported net income of $825M.

When did Illumina, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 31, 2026. It covers the period to June 28, 2026. Its newest filing of any kind is the insider trade from September 10, 2026.

Similar companies

A
Agilent Technologies, Inc.
AVTR
Avantor, Inc.
MTD
Mettler Toledo International Inc/
BRKRP
Bruker Corp
WAT
Waters Corp
RVTY
Revvity, Inc.

Follow ILMN

Get an email when Illumina, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow ILMN: get an email when it files

Where the numbers come from

Financial figures are the values Illumina, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.